SCHEMBL2186033

SCHEMBL2186033

O=[N+]([O-])c1cnc(Cl)cc1CCO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIN1 Q13526 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ PKM P14618 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ GPR35 Q9HC97 1/20 0.35
▸ SNCA P37840 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19064107 0.87 ALDH1A1 (0.37) PIN1ALDH1A1KDM4EMEN1MAPT
SCHEMBL15881241 0.81 SMN1; SMN2 (0.41) PIN1ALDH1A1MAPTHTTSMN1; SMN2
SCHEMBL15173489 0.80 PRKCQ (0.38) PIN1ALDH1A1TSHR
SCHEMBL27712693 0.80 CYP1A2 (0.38) PIN1ALDH1A1MEN1MAPTKMT2A
SCHEMBL4402867 0.78 CYP1A2 (0.38) PIN1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL4402873 0.78 CYP1A2 (0.38) PIN1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL2185792 0.77 VCAM1 (0.36) PIN1ALDH1A1KDM4EMEN1MAPT
SCHEMBL8656469 0.76 HPGD (0.49) PIN1ALDH1A1MAPTTDP1L3MBTL1
SCHEMBL26548248 0.75 TSHR (0.41) PIN1ALDH1A1KDM4EMEN1MAPT
SCHEMBL1982550 0.75 ALDH1A1 (0.44) ALDH1A1MEN1MAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023067546-A1 NOVEL BICYCLIC HETEROARYL DERIVATIVES AS SOS1:KRAS PROTEINPROTEIN INTERACTION INHIBITORS SATYARX PHARMA INNOVATIONS PVT LTD (IN) 2023-04-27 — — WO disclosed
EP-2342190-A1 BICYCLIC KINASE INHIBITORS Novartis AG (CH) 2011-07-13 — — EP disclosed
WO-2010026121-A1 BICYCLIC KINASE INHIBITORS NOVARTIS AG (CH) 2010-03-11 — — WO disclosed
Send feedback